Literature DB >> 9771212

Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.

H Kameda1, J P Pandey, J Kaburaki, H Inoko, M Kuwana.   

Abstract

OBJECTIVE: To examine potential interactions between immunoglobulin (Ig)-allotype gene polymorphisms and susceptibility to systemic sclerosis (SSc) as well as serological expression in SSc patients.
METHODS: IgG heavy chain allotypes G1M(f, z), G2M(n+, n-), G3M(b, g) and Ig light chain allotype KM(1, (1, 2), 3) were genotyped in 105 Japanese SSc patients and 47 race matched normal controls using polymerase chain reaction (PCR) based methods. Associations of each Ig allotype with SSc related antinuclear antibodies were examined in combination with or without MHC class II alleles.
RESULTS: GM/KM genotypic and allelic frequencies were similar in SSc patients and in normal controls. Frequencies of G1M(f) and G2M(n+) were significantly decreased in anticentromere antibody (ACA) positive SSc patients compared with ACA negative SSc patients (p = 0.04 and 0.02, respectively). Conversely, the presence of DQB1*0501 and KM(1, 2) significantly increased the risk of ACA positivity.
CONCLUSION: Ig allotype gene polymorphisms were not associated with susceptibility to SSc. Instead, the results suggested that MHC class II and KM genes are associated with autoimmune responses by interactively promoting the production of ACA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771212      PMCID: PMC1752620          DOI: 10.1136/ard.57.6.366

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

1.  Gm allotypes in white patients with systemic lupus erythematosus.

Authors:  P H Schur; J P Pandey; J A Fedrick
Journal:  Arthritis Rheum       Date:  1985-07

2.  Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.

Authors:  S Pereira; C Black; K Welsh; B Ansell; M Jayson; P Maddison; N Rowell
Journal:  J Rheumatol       Date:  1987-08       Impact factor: 4.666

3.  Gm allotypes in myasthenia gravis.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; H Nishitani; K Ota; T Fujita; K Tsuji
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

4.  A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1).

Authors:  S Whittingham; D N Propert; I R Mackay
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.

Authors:  H Uno; T Sasazuki; H Tamai; H Matsumoto
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

6.  Interaction of HLA and Gm in autoimmune chronic active hepatitis.

Authors:  S Whittingham; J D Mathews; M S Schanfield; B D Tait; I R Mackay
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

Review 7.  Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review.

Authors:  J M Dugoujon; A Cambon-Thomsen
Journal:  Autoimmunity       Date:  1995       Impact factor: 2.815

8.  HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease.

Authors:  E Genth; H Zarnowski; R Mierau; D Wohltmann; P W Hartl
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

9.  Anticentromere antibody and immunoglobulin allotypes in scleroderma.

Authors:  Z Y Chen; J A Fedrick; J P Pandey; R Silver; H R Maricq; H H Fudenberg; R L Dobson; S K Ainsworth
Journal:  Arch Dermatol       Date:  1985-03

10.  HLA and Gm genes in systemic lupus erythematosus.

Authors:  S Whittingham; J D Mathews; M S Schanfield; B D Tait; I R Mackay
Journal:  Tissue Antigens       Date:  1983-01
View more
  6 in total

1.  A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

Authors:  J P Pandey; E C LeRoy
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

2.  Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection.

Authors:  Paolo Muratori; Susan E Sutherland; Luigi Muratori; Alessandro Granito; Marcello Guidi; Georges Pappas; Marco Lenzi; Francesco B Bianchi; Janardan P Pandey
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Michiaki Koga; Nobuhiro Yuki
Journal:  Neurogenetics       Date:  2005-10-29       Impact factor: 2.660

4.  Genetic variations in immunoglobulin G3 and association with staphylococcal intra-mammary infections in cattle and buffaloes.

Authors:  Ravinder Kumar; B R Yadav
Journal:  Mol Biol Rep       Date:  2012-02-12       Impact factor: 2.316

5.  Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Lisa G Rider; Adam Schiffenbauer; Ira N Targoff; Karen Malley; Janardan P Pandey; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2008-10

6.  The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Authors:  Janardan P Pandey; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2013-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.